Varda Space launches $VARDA token at $3B valuation to fund in-orbit pharmaceutical manufacturing.
VC & Fundraising ·
Varda Space Industries, which manufactures pharmaceuticals in orbit using microgravity to improve crystal formation, launched a $VARDA token offering at a $3B valuation to fund its operations. The token round, open on Space Capital Markets until November 30, 2026, requires a minimum commitment of $1,000 in USDG or USDC and targets $500,000 in total raises. Varda has launched nine W-Series capsules to date, with the company holding an FAA license for repeat reentries and United Therapeutics signed as its first commercial space manufacturing partner, with orbital manufacturing set to begin in 2028.